Cargando…
Reinterpreting the Mechanism of Inhibition of Mycobacterium tuberculosisd-Alanine:d-Alanine Ligase by d-Cycloserine
[Image: see text] d-Cycloserine is a second-line drug approved for use in the treatment of patients infected with Mycobacterium tuberculosis, the etiologic agent of tuberculosis. The unique mechanism of action of d-cycloserine, compared with those of other clinically employed antimycobacterial agent...
Autores principales: | Prosser, Gareth A., de Carvalho, Luiz Pedro S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2013
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944805/ https://www.ncbi.nlm.nih.gov/pubmed/24033232 http://dx.doi.org/10.1021/bi400839f |
Ejemplares similares
-
Correction to Reinterpreting the Mechanism of Inhibition
of Mycobacterium tuberculosisd-Alanine:d-Alanine Ligase by d-Cycloserine
por: Prosser, Gareth A., et al.
Publicado: (2013) -
Metabolomics Reveal d-Alanine:d-Alanine Ligase As the Target of d-Cycloserine
in Mycobacterium tuberculosis
por: Prosser, Gareth A., et al.
Publicado: (2013) -
d-Cycloserine destruction by alanine racemase and the limit of irreversible inhibition
por: de Chiara, Cesira, et al.
Publicado: (2020) -
Structure
of the d-Cycloserine-Resistant
Variant D322N of Alanine Racemase from Mycobacterium tuberculosis
por: de Chiara, Cesira, et al.
Publicado: (2023) -
Integron gene cassettes harboring novel variants of d-alanine-d-alanine ligase confer high-level resistance to d-cycloserine
por: Rahman, Md. Ajijur, et al.
Publicado: (2020)